pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: Patent

Sep 8, 2023

Stuart Therapeutics Announces Issuance of U.S. Patent Covering Ophthalmic Anterior Segment Disorders

Sep 5, 2023

Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy

Jul 17, 2023

Precedential US Federal Court Decision Hands SNIPR Biome a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing USA - English USA - English APAC - English

Jun 8, 2023

Cosette Pharmaceuticals Acquires Intrarosa from Endoceutics, Inc.

May 17, 2023

Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio

May 16, 2023

CANTEX PHARMACEUTICALS ANNOUNCES ISSUANCE OF A PATENT FOR AZELIRAGON AS A TREATMENT OF GLIOBLASTOMA

May 16, 2023

HuidaGene Therapeutics' Novel DNA Gene-Editing System Cas12i Patent Granted by USPTO USA - English Deutschland - Deutsch France - Français

May 1, 2023

Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy

Apr 20, 2023

Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy

Apr 6, 2023

AOBiome Therapeutics Granted Composition of Matter Patent for its Clinical Candidate B244

Apr 4, 2023

IgGenix Announces Patent Granted by USPTO Covering the Generation of Allergen-specific Antibodies

Apr 4, 2023

Microbion Corp. Granted US Patent for the Use of Inhaled Pravibismane for Pulmonary Infections

Mar 16, 2023

CancerVax Files Non-Provisional Patent for Universal Cancer Vaccine

Mar 13, 2023

Combined Therapeutics Granted Patent for its mRNA Vaccine Platform by USPTO

Mar 7, 2023

NanOlogy Granted a US Patent for Its Investigational Drugs in Combination with Immune Checkpoint Inhibitors in the Treatment of Cancer

Jan 17, 2023

Phanes Therapeutics' anti-claudin 18.2 antibody patent granted in the US

Jan 9, 2023

Bexson Biomedical Issued USPTO Patent on Proprietary Formulation Technology, SEVALENT™

Jan 5, 2023

Vivera Expands TABMELT Global Licensing Reach with Grant of Israel Patent

Dec 22, 2022

SNIPR Biome further strengthens CRISPR/Cas IP portfolio with patent grant USA - English USA - English

Dec 6, 2022

EpicentRx Announces Patent Issued for Radiation Protection with RRx-001 in Combination Regimens

Nov 28, 2022

Cimeio Therapeutics Announces Issuance of Key Patent Covering Cell Therapy Platform

Nov 28, 2022

Therapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative Conditions

Nov 14, 2022

Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office

Nov 2, 2022

Revolo Biotherapeutics Awarded Patent for ‘1104 in Acute Treatment of Relapsing Remitting Conditions

Oct 27, 2022

TABMELT Granted Patent Allowance in Israel, Expanding Vivera's Global Licensing Reach USA - English USA - English

Oct 27, 2022

TABMELT Granted Patent Allowance in Israel, Expanding Vivera's Global Licensing Reach

Oct 25, 2022

Vivera Enters $6B Market with Speech Assessment and Feedback Device Patent Allowance

Oct 13, 2022

Palleon Announces Issuance of a U.S. Patent for Use of Antibody Sialidase Conjugates

Oct 10, 2022

Therapeutic Solutions International Granted Landmark United States Patent on Ability of QuadraMune Nutraceutical to Repair Injured Brains

Oct 5, 2022

Prokarium Strengthens Patent Position Through Notice of Allowance of US Patent for Immunotherapy Prime in Combination with Cell Therapies

Oct 4, 2022

Microbion Corporation Announces Granting of a US Patent for a Pharmaceutical Composition of Pravibismane USA - English USA - English

Oct 4, 2022

Microbion Corporation Announces Granting of a US Patent for a Pharmaceutical Composition of Pravibismane

Oct 3, 2022

Eligo Bioscience further strengthens its position as leader in the field of gene editing of the microbiome with additional landmark CRISPR patent

Sep 28, 2022

Vivera Receives 3rd Patent for ZICOH, Expanding Into $500B Prescription Market

Sep 21, 2022

Linnaeus Therapeutics Announces Issuance of Patent for LNS8801 by the U.S. Patent and Trademark Office

Sep 20, 2022

U.S. Patent Office Issues Trethera Composition of Matter Patent Covering TRE-515, Extending Market Exclusivity to Late 2041

Sep 20, 2022

Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™ Compositions

Sep 15, 2022

Bexson Biomedical Granted USPTO Patent Allowance on Proprietary Formulation Technology, SEVALENT™

Sep 14, 2022

Lutris Pharma Receives Notice of Allowance for Patent Covering the Use of B-Raf Inhibitors in MEK Inhibitor induced rash USA - English USA - English USA - English

Sep 14, 2022

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Sep 14, 2022

Lutris Pharma Receives Notice of Allowance for Patent Covering the Use of B-Raf Inhibitors in MEK Inhibitor induced rash USA - English Israel - English

Sep 7, 2022

Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio

Aug 29, 2022

Therapeutic Solutions International Develops Gene Silencing Therapy for Acute Respiratory Distress Syndrome

Aug 16, 2022

Propanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent Office

Aug 2, 2022

Phanes Therapeutics' anti-CD47 antibody patent granted in the US

Jul 28, 2022

ViiV Healthcare and the Medicines Patent Pool Sign New Voluntary Licensing Agreement to Expand Access to Innovative Long-Acting HIV Prevention Medicine

Jul 11, 2022

Lutris Pharma Receives Notice of Allowance for Key U.S. Patent Application Covering Lead Compound, LUT014, a Novel B-Raf Inhibitor USA - English USA - English USA - English

Jul 11, 2022

Lutris Pharma Receives Notice of Allowance for Key U.S. Patent Application Covering Lead Compound, LUT014, a Novel B-Raf Inhibitor USA - English Israel - English

Jul 5, 2022

Propanc Biopharma’s CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictions

Jun 22, 2022

BioAxone BioSciences Announces Patent Issued for Pharmaceutical Compositions of BA-210, a Rho Inhibitor for the Treatment of Spinal Cord Injury

Jun 21, 2022

BlueAllele Corporation continues to advance therapeutic approaches using novel gene correction technologies and secures third patent from the USPTO

Jun 9, 2022

7 Hills Pharma Expands Pioneering Patent Portfolio With New Claims Covering Innovative Combination Therapies

Jun 7, 2022

Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl

May 31, 2022

Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin

May 25, 2022

Vivera Receives 3rd U.S. Patent Allowance for ZICOH Drug Delivery Device

May 24, 2022

Calidi Biotherapeutics Granted U.S. Patent for Proprietary Therapeutic Delivery Platform, Strengthening Company’s Intellectual Property Position in Immunotherapy

May 24, 2022

PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent

Apr 26, 2022

Antios Therapeutics Announces Notice of Allowance for U.S. Patent on Phosphoramidates for the Treatment of Hepatitis B Virus

Apr 26, 2022

Amicrobe, Inc., Developer of Novel Synthetic Biologics, Adds Fifth U.S. Patent to Intellectual Property Portfolio USA - English España - español France - Français Deutschland - Deutsch

Apr 21, 2022

Vivera Enters $23 Billion Telehealth Industry with Patent Allowance for MDZone

Apr 13, 2022

Renibus Therapeutics Strengthens IP Position with Additional US Patent

Apr 12, 2022

Phanes Therapeutics' anti-CD73 antibody patent granted in the US

Mar 30, 2022

Mapi Pharma Receives U.S. Patent Covering Methods of Suppressing or Alleviating Primary or Secondary Progressive Multiple Sclerosis with a Sustained Release Glatiramer Acetate Depot

Mar 29, 2022

Artizan Biosciences Announces Issuance of New U.S. Patent to Cover Proprietary Discovery Platform

Mar 29, 2022

BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Notice of Allowance for the Company’s United States Patent Claims on Reduction of Side Effects Caused by Radiation Therapy Combined with Chemotherapy

Mar 29, 2022

Eleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-Psilo

Mar 23, 2022

ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS

Mar 22, 2022

Propanc Biopharma Receives Notice of Allowance for Method to Treat Cancer Stem Cells from the US Patent and Trademark Office

Mar 15, 2022

Microbion Corporation Announces Granting of a US Patent for the Use of Topical Pravibismane for Diabetic Foot Ulcer Infections

Mar 14, 2022

Catamaran Bio Expands Collaboration for CAR‑NK Cell Engineering with the University of Minnesota and Secures an Exclusive Patent License to Next Generation Manufacturing Technologies

Mar 14, 2022

OncoTEX Issued New U.S. Patent for Ovarian Cancer-Fighting Drug OxaliTEX

Mar 10, 2022

BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Expanding Patent Portfolio Successes for Supportive Cancer Drugs Designed to Prevent Radiation Therapy Side Effects

Mar 10, 2022

Therapeutic Solutions International Granted Second United States Patent on QuadraMune for Prevention, Inhibition, and Treatment of COVID-19

Mar 9, 2022

BriOri BioTech Inc. Granted Patent for Topical Formulation of Vioxx

Feb 22, 2022

BlueAllele Corporation Secures Second Patent from USPTO Strengthening the Company's Position in Targeted Insertion and Gene Correction Technologies

Feb 15, 2022

BriOri BioTech Inc. Granted Patent for Topical Formulation of Rofecoxib

Feb 14, 2022

Actym Therapeutics Announces Issuance of US Patent

Feb 8, 2022

Aphios Granted US Patent For Combination HIV Latency Nanoparticles Towards an HIV Cure

Feb 8, 2022

Salipro Biotech Receives European Patent for Antigen production

Feb 4, 2022

Phanes Therapeutics' antibody patent granted

Jan 14, 2022

Oblique Therapeutics is pleased to announce that the United States Patent and Trademark Office has granted a patent for its innovative AbiProt technology

Jan 12, 2022

Tevogen Bio™ Further Strengthens IP Portfolio With Additional Patent for Method of Preparing Its Investigational SARS-CoV-2 Specific T cell Therapy

Dec 29, 2021

Tevogen Bio Reinforces IP Portfolio With Additional US Patent for Its Investigational T Cell Therapy for Treatment of COVID-19

Dec 28, 2021

Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment

Dec 21, 2021

ExCellThera announces settlement of its patent infringement claims against Selleck Chemicals

Dec 20, 2021

Second Genome Granted U.S. Patent for Proteins for the Treatment or Prevention of Epithelial Barrier Function Disorders

Dec 15, 2021

Confo Therapeutics Expands Patent Estate for ConfoBody-based GPCR Screening Platform

Dec 9, 2021

Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform

Dec 8, 2021

Tevogen Bio Announces U.S. Patent and Trademark Office Has Granted Patent for Preparation of Tevogen’s SARS-CoV-2 Specific Allogeneic Cytotoxic T Lymphocytes (CTL) and Methods of Treatment Using Tevogen’s Investigational CTL Therapy for COVID-19

Dec 2, 2021

Eligo Bioscience Announces Successful Outcome in US Patent Interference against SNIPR Biome on CRISPR-Cas antimicrobials

Nov 17, 2021

Saghmos Therapeutics Announces Issuance of US Patent for ST-62516 for the Reduction of Kidney Injury in Patients with Chronic Kidney Disease Undergoing Contrast Procedures

Nov 15, 2021

ElevateBio Announces Issuance of U.S. Patent Providing Protection for RNA-Guided Nucleases Identified through its Life Edit Gene Editing Platform

Nov 10, 2021

Aphios Granted Chinese Patent for Novel Bryoid to Treat Alzheimer’s Disease

Nov 2, 2021

Evox Therapeutics Expands Its Exosome Patent Portfolio

Oct 19, 2021

PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody

Oct 7, 2021

LIPAC Oncology Secures Broad Patent Protection for Proliposomal Paclitaxel Compositions Formulated for Delivery to the Bladder and Ureter for the Treatment of Solid Tumor Carcinomas

Oct 4, 2021

Starton Therapeutics Announces Notice of Allowance for U.S. Patent Application Protecting Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents

Sep 28, 2021

Orbus Therapeutics Granted European Patent for Method of Use for Eflornithine

Sep 22, 2021

Therapeutic Solutions International Discovers and Files Patent on Novel Cellular Therapy Combination for Augmentation of Lung Repair in COVID-19 Model

Sep 10, 2021

Lennham Pharmaceuticals Expands Leading Psilocybin Patent Portfolio with Addition of New Patent Family

Sep 9, 2021

USPTO Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies

Sep 9, 2021

PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer

Aug 27, 2021

ZICOH Technology by Vivera Granted Second U.S. Patent (US 11,090,449) for Smart Inhaler Device

Aug 20, 2021

Vivera Pharmaceuticals Receives U.S. Patent (US 11,083,850) for ZICOH

Aug 10, 2021

Kineta Announces Patent Issuance for U.S. Patent Covering Composition of Matter of KCP506, a Novel Non-opioid Therapy for Chronic Pain

Jul 22, 2021

ZYUS Life Sciences Strengthens Software Patent Portfolio Supporting Clinical Development

Jul 20, 2021

CureLab Oncology Granted US Patent for Therapeutic Use of its Lead Product in ALS, Alzheimer's, Huntington's, and Parkinson's Diseases

Jul 1, 2021

OWP Pharmaceuticals Announces Patent Issuance for the First-Ever Oral Liquid Suspension of Quetiapine for the Treatment of Schizophrenia and Bipolar Disorder

Jun 29, 2021

Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions

Jun 23, 2021

Inotrem Adds a New Strategic Asset to Its Immunotherapy Anti-TREM-1 Drug Pipeline

Jun 1, 2021

ERS Genomics: Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent and Allows Third

May 27, 2021

ONK Therapeutics Secures Exclusive Global License to Patent for CISH Knockout in NK Cells for the Treatment of Cancer, from Australia’s WEHI

May 25, 2021

ZYUS Life Sciences Receives Notice of Allowance for Canadian Patent Application Covering Pain Management

May 25, 2021

Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary Judgment

May 20, 2021

Vivera Pharmaceuticals Granted Allowance for ZICOH Patent

May 14, 2021

Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Deuterated Psilocybin Products

Apr 29, 2021

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Apr 22, 2021

OWP Pharmaceuticals Announces Patent Application for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder

Apr 21, 2021

BioCurity Pharmaceuticals Inc. Files a US Provisional Patent Application Drawn to Pharmaceutical Formulations of Cerium Oxide Nanoparticles Designed to Prevent Radiation Therapy Side Effects for Cancer Patients Undergoing Radiation Therapy

Mar 30, 2021

Aphios Granted US Patent for Novel, More Potent Bryoid to Treat Alzheimer’s diseases, HIV-1 Latency, Prostate Cancer, Glaucoma and Multiple Sclerosis

Mar 16, 2021

Vesigen Therapeutics Announces Issuance of U.S. Patent for Broad Applications of ARMMs Technology

Mar 8, 2021

ReForm Biologics Announces the Issuance of Chinese Patent for Therapeutic Protein Formulations

Mar 3, 2021

Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the U.S. Patent and Trademark Office

Feb 25, 2021

TABMELT Granted Patent Rights in Russia, Expanding Vivera Global Licensing

Feb 16, 2021

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma

Jan 26, 2021

Dynacure Announces Issuance of U.S. Patent for DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)

Jan 26, 2021

Codagenix Secures U.S. Patent for Codon-Deoptimized RSV Vaccine Candidates

Jan 19, 2021

AbCellera Granted U.S. Patent Covering its Trianni Mouse Technology

Dec 29, 2020

Lipocine Announces Update on Jury Trial in Patent Infringement Lawsuit Against Clarus Therapeutics

Dec 23, 2020

Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations

Dec 16, 2020

WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart Failure With Newly Issued U.S. Patent

Dec 7, 2020

The Regents of the University of California and Evolve BioSystems Win Court Order, Denying Abbott's attempt to Dismiss Patent Infringement Suit

Dec 1, 2020

Calidi Biotherapeutics Announces European Patent Granted by EPO: Combination Immunotherapy Approach for Treatment of Cancer

Dec 1, 2020

Vivlion GmbH Signs Worldwide License Agreement With ERS Genomics for CRISPR/Cas9 Patent Portfolio

Dec 1, 2020

Aphios Granted US Patent for Combination Therapeutic to Treat Neurodegenerative Diseases

Nov 24, 2020

Evox Therapeutics expands its existing exosome patent portfolio

Nov 17, 2020

Factor Bioscience Successfully Defends mRNA Gene Editing Patent USA - English Россия - English Россия - Pусский

Nov 10, 2020

Factor Bioscience Granted Second U.S. Patent for mRNA Vectorization of TALENs Technology

Oct 16, 2020

U.S. Patent Office Grants Renew Biopharma Pivotal Patent for Cannabinoid Biosynthesis

Oct 15, 2020

XenoTherapeutics Granted U.S. Patent Covering Method of Producing Clinically Acceptable Porcine Cells, Tissues, and Organs for Human Xenotransplantation

Oct 2, 2020

BioCurity Pharmaceuticals Inc. ('BioCurity') Announces Issuance of European Patent for Reduction of Side Effects Caused by Radiation Therapy Combined with Chemotherapy

Oct 1, 2020

Jupiter Orphan Therapeutics Announces U.S. Patent for Its Resveratrol Formulation

Sep 14, 2020

ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case

Aug 25, 2020

Cytovia Therapeutics and NYSCF Announce Filing of Provisional Patent for iPSC-Derived NK Cells to Produce Unlimited On-Demand NK and CAR-NK Cells for the Treatment of Cancer

Aug 12, 2020

Novome Biotechnologies Expands Therapeutic Focus and Platform Capabilities with Acquisition of Preclinical Projects and Intellectual Property from Caribou Biosciences and License to CRISPR-Cas9 Foundational Patent Portfolio

Aug 4, 2020

7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies

Jul 23, 2020

Phosplatin Therapeutics Receives Notice of US Patent Issuance for PT-112 as Therapeutic Agent for Treatment of Bone or Blood Cancers

Jul 15, 2020

Evox Therapeutics Expands Existing Exosome Patent Portfolio With Further Grant Covering Exosomes for RNA Therapeutics

Jul 13, 2020

ARS Pharmaceuticals Announces New Patent on ARS-1 (epinephrine nasal spray)

Jul 10, 2020

AbCellera Files Patent Infringement Lawsuit Against Berkeley Lights, Inc.

Jul 9, 2020

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering its Combination Product Candidate for the Treatment of Viral or Virally-Induced Conditions

Jul 8, 2020

OWP Pharmaceuticals Announces Patent Application for the First-Ever Powder for Oral Liquid Formulation of Duloxetine Hydrochloride for the Treatment of Major Depressive and Generalized Anxiety Disorder

Jul 7, 2020

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

Jul 7, 2020

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

Jun 9, 2020

Pandion Therapeutics Announces Issuance of U.S. Patent for Bifunctional Molecules Derived from TALON™ Platform

Jun 9, 2020

Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ ISAC Technology and its Lead Development Candidate, BDC-1001

Jun 3, 2020

Kymab announces that the US Patent Trial and Appeal Board rejects a fifth request by Regeneron for invalidation of Kymab’s US patents

May 27, 2020

Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimicrobial Nu-8 Bisphosphocin

May 26, 2020

Factor Bioscience Granted U.S. Patent for mRNA Vectorization of TALENs Technology

May 14, 2020

Kymab announces that the US Patent Trial and Appeal Board rejects requests for invalidation filed by Regeneron

May 4, 2020

Inositec Granted US Composition of Matter Patent for Cardiovascular Calcification Inhibitor INS-3001

Apr 30, 2020

Starton Therapeutics Files PCT and US Patent Application for Continuous Delivery of Lenalidomide and Class of Immunomodulatory Agents

Apr 14, 2020

Propanc Biopharma Receives First Allowance for Key Patent Family from Australian Patent Office

Mar 24, 2020

AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States

Mar 19, 2020

Receptor Life Sciences Secures U.S. Patent for its Oral Absorption Enhancing Excipients with Cannabinoids

Feb 27, 2020

BERG Files Patent Application For First In Class Small Molecule Modulators Of A Novel Target Identified By BERG's Interrogative Biology Platform

Feb 24, 2020

Antios Therapeutics Announces Notice of Allowance for a U.S. Patent Application Covering ATI-2173

Feb 10, 2020

ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings

Jan 28, 2020

Aphios Granted US Patent For Combination HIV Latency Nanotherapeutic Towards an HIV Cure

Jan 17, 2020

ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding the Revocation of Broad Institute CRISPR Patent

Jan 15, 2020

Synedgen Granted New EU Patent For Treating GI Mucositis

Jan 8, 2020

NeuroRx Drug for Suicidal Bipolar Depression Receives Notification of Patent Allowance

Jan 8, 2020

OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder

Dec 16, 2019

CORRECTING and REPLACING BioAxone BioSciences Expands Patent for Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors

Dec 5, 2019

Aphios Granted US Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases

Dec 3, 2019

Centrexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Pipeline Candidate CNTX-4975

Dec 3, 2019

OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder

Nov 20, 2019

ReForm Biologics Announces Issuance of U.S. Patent on Additional Excipients for Therapeutic Protein Formulations

Nov 20, 2019

OWP Pharmaceuticals Announces IND Approval and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Topiramate for the Treatment of Epilepsy and Migraine

Nov 7, 2019

AbCellera Announces the Issuance of Foundational Patent Claims Around Microfluidic Screening Assays for Antibody Discovery

Oct 1, 2019

Renew Biopharma Announces Landmark Patent in Cannabinoid Biosynthesis; CEO to Speak Today at SynBioBeta

Sep 30, 2019

Evolve BioSystems And The Regents Of The University Of California Jointly File Patent Infringement Complaint Against Abbott Laboratories Regarding Infant Probiotic

Sep 25, 2019

89bio Announces Dosing of First Patients in NASH Study and Issuance of Composition of Matter Patent

Sep 25, 2019

OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients

Sep 25, 2019

Arbor Biotechnologies Announces Issuance of U.S. Patent for CRISPR-Cas13d

Sep 24, 2019

United States Patent and Trademark Office Issues Innate Biologics™ E3 Ligase Effector Protein Patent

Sep 3, 2019

Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis

Aug 21, 2019

Intrommune Therapeutics Receives Formulation Patent Notice of Allowance

Aug 14, 2019

Forge Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office Covering Novel Chemistry Targeting LpxC For The Treatment Of Gram-Negative Bacterial Infections

Jul 24, 2019

Cognition Therapeutics Extends IP Coverage of Alzheimer’s Therapeutic Elayta™ to Additional Major Pharmaceutical Markets with Patent Issuances in Japan and China

Jul 18, 2019

GigaGen Announces Issuance of US Patent for Functional Analysis Methods in the Discovery and Development of Therapeutic Antibodies

Jun 26, 2019

ERS Genomics Provides Comment on New Patent Interference With the Broad Institute Relating to Invention of the CRISPR/Cas9 System

Jun 19, 2019

Incysus Therapeutics Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology

May 24, 2019

EpimAb Biotherapeutics is Granted US Patent on Core Bispecific Antibody Technology

May 22, 2019

MaaT Pharma Expands Patent Portfolio with Three Granted Patents Covering its Microbiome Restoration Biotherapeutic Platform

May 21, 2019

HIV Cure Program Patent Granted To American Gene Technologies

May 16, 2019

CureVac Granted Patent Claiming the Combination of mRNA Vaccines with Anti-PD-L1 Antibodies

May 16, 2019

CureVac erhält Patent für die Kombination mRNA-basierter Impfstoffe und Anti-PD-L1-Antikörper

May 8, 2019

ReForm Biologics Announces Issuance of U.S. Patent on Stabilizing Excipients for Therapeutic Protein Formulations

May 7, 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

May 1, 2019

Karuna Completes $80 Million Series B Financing

Apr 8, 2019

ReViral Announces Grant of Key US Composition of Matter Patent for Their Respiratory Syncytial Virus Inhibitor Programme

Apr 3, 2019

Clarus Therapeutics Refutes Patent Infringement Complaint

Apr 2, 2019

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

Mar 20, 2019

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases

Mar 13, 2019

Propanc Biopharma Receives Notice of Allowance for Additional Claims from Foundation Patent in the U.S.

Mar 12, 2019

ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent Including Uses of CRISPR ‘in a cell’

Mar 8, 2019

Intrommune Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy for Food Allergy

Feb 21, 2019

Cognition Therapeutics Receives European Patent Covering its Alzheimer's Disease Candidate, Elayta™

Feb 19, 2019

Generex Biotechnology Subsidiary Regentys Corporation Receives Approval of Japanese Patent for Extracellular Matrix Hydrogel (Regentys ECMH™)

Feb 14, 2019

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Deuterated Norketamine and Related Compounds

Feb 13, 2019

Poseida Therapeutics Announces Notice of Allowance for New Patents and Registration of New Trademarks

Feb 7, 2019

New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies

Feb 6, 2019

Palleon Pharmaceuticals Announces Successful Defense of European Patent

Jan 30, 2019

Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued

Jan 8, 2019

CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants Against RSV

Jan 8, 2019

CureVac erhält US-Patent für mRNA-basierte RSV-Impfung von Säuglingen

Jan 7, 2019

Apic Bio Announces $40M Series A Financing to Advance Novel Gene Therapies for Rare Genetic Disorders

Jan 4, 2019

ViaCyte Provides Update on Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Jan 2, 2019

AOBiome Therapeutics Expands Intellectual Property Estate with Issuance of U.S. Patent for Use of Ammonia Oxidizing Bacteria (AOB) for the Treatment of Eczema

Dec 14, 2018

Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis

Dec 11, 2018

NexImmune Granted Key US Patent for Core E+E Technology

Dec 10, 2018

Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill

Nov 28, 2018

Vor Biopharma Announces Issuance of Foundational U.S. Patent Broadly Covering Compositions and Methods to Treat Hematologic Malignancies

Nov 15, 2018

OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues USA - English France - Français Deutschland - Deutsch

Nov 15, 2018

OxThera AB is Being Granted US Patent for Oxalobacter Secretagogues USA - English USA - Français USA - Deutsch

Oct 25, 2018

Calidi Biotherapeutics, Inc. Granted New Patent from USPTO for Cell-Based Delivery Of Oncolytic Vaccinia Viruses

Oct 23, 2018

Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering

Oct 23, 2018

Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

Oct 16, 2018

Velicept Therapeutics Raises an Additional $15 Million in Series B Round, Initiates Phase 2b Study Evaluating Once Daily Dosing of Solabegron in Patients with Overactive Bladder (OAB) and Receives Issuance of Additional U.S. Patent

Oct 11, 2018

Intellectual Property Protection for Tetra Discovery Partners’ BPN14770 Boosted with Issuance of New U.S. Patent

Sep 10, 2018

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology

Sep 2, 2018

SanBio: Acquisition of a Patent Portfolio Regarding Cell Medicines Derived from Mesenchymal Stem Cells

Aug 8, 2018

BioAxone BioSciences Receives Notice of Allowance on Patent for Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors

Jul 26, 2018

Batu Biologics Files Patent on Patient Selection for Right to Try Law

Jul 11, 2018

ReForm Biologics Announces New Patent on Surfactant Replacement Excipients to Stabilize Antibody-Based Therapeutics

Jul 10, 2018

BioAxone BioSciences Receives Notice of Allowance for Composition of Matter Patent Covering Novel ROCK2 Inhibitor

Jun 19, 2018

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing

Jun 19, 2018

Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation

Jun 5, 2018

Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology

Apr 17, 2018

ViaCyte Substantially Expands Patent Portfolio in Stem Cell-Derived Cell Replacement Therapies for Type 1 Diabetes and Other Indications

Apr 3, 2018

Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics

Mar 22, 2018

CureVac Receives U.S. Patent Covering Entire Process for Pharmaceutical Manufacturing of RNA

Mar 19, 2018

Velicept Therapeutics Initiates First of Two Phase 2b Dose-Ranging Studies of Solabegron in Patients with Overactive Bladder (OAB); Finalizes Novel, Once Daily Formulation; and Receives U.S. Patent Covering OAB

Mar 19, 2018

American Gene Technologies Gains Additional Immuno-Oncology Patent

Mar 6, 2018

PepVax Announces Filing of Provisional Patent Application for SMARTmid DNA Platform and Other Updates

Feb 13, 2018

ReForm Biologics Secures New Patent Expanding Coverage of Key Excipient Formulation for Antibody-Based Therapeutics

Feb 9, 2018

Medac Pharma, Inc. Announces The Patent Trial And Appeal Board (PTAB) Upheld Patents On Rasuvo (Single Dose Auto-Injection Of Methotrexate)

Jan 30, 2018

Skin Biology Receives US Patent for Non-toxic Skin Cancer Therapy With Copper Peptides

Jan 18, 2018

ERS Genomics Responds to Revocation of Broad Institute European Patent

Jan 9, 2018

Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Oral Compositions of Ketamine and Related Compounds

Jan 2, 2018

NanOlogy™ to Present Update on Cancer Treatment Clinical Program at Biotech Showcase in San Francisco

Dec 12, 2017

American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells

Nov 29, 2017

Synaffix Commands IP Space of Glycan-Conjugated ADCs Through Major Expansion of Granted Patent Portfolio

Nov 22, 2017

ERS Genomics Provides Update on U.S. Patent Interference Process

Nov 14, 2017

Neuronascent Granted Composition of Matter Patent in Europe for Oral Neuron Regenerative Technology

Nov 8, 2017

Mitochon Pharmaceuticals Announces First Patent Allowance for Mitochondrial Targeted Therapies for Neurodegeneration

Nov 8, 2017

OxThera Strengthens Patent Portfolio for Treatment of Hyperoxaluria

Nov 7, 2017

Neurelis Expands Worldwide Patent Portfolio With Latest Issuance In Japan

Oct 24, 2017

Cognition Therapeutics Announces Issuance of Broad Composition of Matter Patent for CT1812, a First-in-Class Alzheimer’s Disease Clinical Candidate

Oct 18, 2017

Pharmazz, Inc. has received exclusive license to U.S. patent for treatment of opioid tolerance and pain management

Oct 17, 2017

Eos Biosciences Announces Issuance of Additional U.S. Patent For Targeted Breast Cancer Therapy

Oct 11, 2017

Longevity Biotech Granted US Patent Covering Hybridtide Platform Technology for Stabilized Peptide Therapeutics

Sep 20, 2017

AOBiome Expands Intellectual Property Estate, Announces Issuance of U.S. Patent for Ammonia Oxidizing Bacteria (AOB) for the Treatment of Acne

Sep 13, 2017

Eos Biosciences Announces Issuance of U.S. Patent for Novel Oncology Theranostic

Jul 25, 2017

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing

Jul 20, 2017

CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies

Jul 18, 2017

Centrexion Therapeutics Provides Updates and Advancements for Pipeline of Chronic Pain Treatments

May 30, 2017

Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods of Treatment with Therapeutics Based on Bacterial Spore Fractions of Microbiota Obtained From Human Donors

May 25, 2017

Neurana Pharmaceuticals Receives Notice of Allowance of Patents For Tolperisone, a Novel Skeletal Muscle Relaxant

May 23, 2017

Origenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment of Neurodegenerative and Inflammatory Diseases

May 16, 2017

Synaffix Secures End-to-End Patent Protection of Its ADC Technology Platform as Its HydraSpace™ Patent Grants in the United States

May 15, 2017

Immunomic Therapeutics Announces Exclusive License of Phase II Cancer Immunotherapy Technology Targeting Cytomegalovirus (CMV)

May 13, 2017

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision

May 10, 2017

Caribou Biosciences Announces Grant of a Key CRISPR-Cas9 Genome Editing Patent in Europe

May 3, 2017

Treos Bio Announces Filing of Key Patent Applications on its Precision Therapeutic Cancer Vaccine Development Platform and its Compositions for Colorectal and Breast Cancers

May 2, 2017

Caribou Biosciences Announces Grant of a Key CRISPR-Cas9 Patent in the U.S.

May 1, 2017

ReForm Biologics Announces Issuance of U.S. Patent for New Excipient to Improve Antibody-Based Therapeutics

Feb 15, 2017

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.

Feb 7, 2017

Emmaus Life Sciences, Inc. Receives Notice of Allowance for Japanese Patent for use of L-glutamine in Treatment of Diabetes

Feb 3, 2017

Pharmazz, Inc. initiates human phase II studies of PMZ-2010 for the treatment of hemorrhagic shock and presents data at the Society of Critical Care Medicine Annual Meeting

Feb 1, 2017

Emmaus Life Sciences, Inc. Receives Notice of Allowance for U.S. Patent for use of L-glutamine in Treatment of Diverticulosis

Jan 26, 2017

Knopp Biosciences Receives Key Patent Directed to Ion Channel Activators for Brain Disorders

Jan 24, 2017

Neuronascent Announces Third US Patent Issued Covering Therapeutics for Neurodegenerative and Neuropsychiatric Disorders

Jan 4, 2017

Knopp Biosciences Receives Key Patent Directed to Treatment for Hypereosinophilic Syndromes, Asthma, and Other Eosinophilic Diseases

Dec 20, 2016

Evolve BioSystems Successfully Defends European Patent Opposition by Danone, Maintaining Their Position as Leaders in the Infant Gut Microbiome Space

Dec 13, 2016

Emmaus Life Sciences, Inc. Receives Japanese Patent for use of L-glutamine in Treatment of Diverticulosis

Dec 8, 2016

Key Synaffix Patent Covering Glycan-Conjugated ADC Process Granted in the United States

Nov 30, 2016

Pharmazz, Inc. advances its product pipeline for the treatment of stroke, strengthens patent portfolio and presents hemorrhagic shock data at the American Heart Association

Nov 22, 2016

Immunomic Therapeutics Announces Expansion of IP Portfolio

Nov 9, 2016

SanBio Granted Key Patent in Treatment for Traumatic Brain Injury

Nov 8, 2016

CureVac Receives Broad Patent for RNAntibody Technology

Nov 7, 2016

Karolinska Development company Modus Therapeutics granted U.S. patents for sickle cell disease drug candidate sevuparin

Oct 19, 2016

Vedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia

Oct 18, 2016

NeuroRx solidifies Intellectual Property Position - receives notice of Allowance by US Patent Office

Oct 17, 2016

Metacrine Expands Patent Portfolio for Novel FGF-1 Program to Treat Diabetes

Oct 13, 2016

Clarus Therapeutics Provides Update on Patent Infringement Lawsuit Against Lipocine’s Oral Product for Testosterone Replacement Therapy

Oct 11, 2016

Rebiotix Receives Patent from the USPTO for Microbiota Restoration Therapy

Sep 6, 2016

Vedanta Biosciences Granted Third U.S. Patent Covering Methods of Treating Infectious and Allergic Diseases with Bacterial Consortia

Aug 23, 2016

Vedanta Biosciences Granted Second U.S. Patent Covering Methods of Treating Autoimmune Disease with Therapeutics Based on Bacterial Consortia

Aug 16, 2016

Vedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia

Aug 16, 2016

Avion Pharmaceuticals, LLC Renews Ongoing Partnership With Gnosis, S.P.A., To License Quatrefolic, Body-ready Folate, Through Patent Life Of 2028

Aug 10, 2016

Leading BioSciences Expands U.S. Patent Portfolio for Lead Candidate LB1148

Aug 9, 2016

Alcyone Lifesciences, Inc. Announces Allowance of First Patent Related to ReFlow™ System for the Treatment of Hydrocephalus

Jul 29, 2016

Quark Pharmaceuticals Awarded Key Patent for QPI-1007 Ocular Neuroprotectant

Jun 2, 2016

Intensity Therapeutics Issued First US Patent for Immune-based Cancer Therapeutic Agents

May 26, 2016

Gelesis Announces First U.S. Patient Enrolled in Pivotal Gelesis100 Weight-Loss Study

May 16, 2016

SanBio Granted Key Patent in Treatment for Macular Degeneration

Apr 25, 2016

ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

Apr 25, 2016

ViiV Healthcare et Medicines Patent Pool étendent la licence du Dolutegravir à tous les pays à revenu intermédiaire de la tranche inférieure

Apr 22, 2016

Pharmazz, Inc. strengthens its patent portfolio with Notice of Issuance for PMZ-2123 (BQ123) in the treatment of diabetic ketoacidosis

Apr 21, 2016

Leading BioSciences Announces Issuance of U.S. Patent for Lead Clinical Asset LB1148

Mar 30, 2016

Vedanta Biosciences Announces License Agreement with RIKEN and other Japanese Institutions for New Immune Boosting Microbiome Technology

Mar 17, 2016

MiNA Therapeutics Granted US Patent Covering Small Activating RNAs Targeting the CEBPA Gene

Mar 2, 2016

New Patent Issued to Cantex Pharmaceuticals for Its Lead Product Candidate in the Treatment of Thrombocytopenia and Neutropenia

Mar 1, 2016

Intrommune Therapeutics Announces Issuance of U.S. Patent Covering Oral Mucosal Immunotherapy for Food Allergy

Feb 10, 2016

Telephus Medical LLC Announces Australian Patent for Therapeutic Antibodies to Treat Staphylococcus aureus Infections

Feb 8, 2016

VLP Therapeutics Announces Issuance of U.S. Composition of Matter Patent for i-α Virus Like Particle Platform Technology

Jan 27, 2016

Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology

Jan 27, 2016

Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology

Jan 26, 2016

kaléo Announces the Award of Its 100th Patent

Jan 18, 2016

Telephus Medical LLC Announces Issuance of Japanese Patent for Anti-MRSA Antibodies

Dec 16, 2015

Symic Receives New U.S. Patent for Osteoarthritis Program

Jul 30, 2015

Cleave Biosciences Granted Key U.S. Patent Covering CB-5083

Jul 14, 2015

CereSpir Incorporated Obtains New Patent From USPTO Covering the Optimal Synthetic Route for Commercial Manufacture of CSP-1103 in Late Stage Development to Slow the Progression of Mild Cognitive Impairment Due to Alzheimer's Disease

Jul 8, 2015

Cortice Biosciences Announces Issuance of a Key Patent Covering the Company's Alzheimer's Disease Drug Development Program

Jun 15, 2015

Batu Biologics Reports Combination Therapy Boosts Results in Tumor Blood Vessel-Killing Strategy

Jun 9, 2015

MicroBiome Therapeutics Presents Clinical Data On Diabetes Drug NM505 At ADA's 75th Scientific Sessions And Reports Issuance Of NM505 Patent

May 20, 2015

Aphios Granted United States Patent for Alzheimer’s Disease Treatment

May 19, 2015

Batu Biologics Files Patent on Blood Derived Anti-Cancer Immunomodulator

May 18, 2015

Allegro Ophthalmics Announces Issuance of U.S. Patent for First-in-Class Integrin Peptide Therapy Candidate Luminate

Apr 23, 2015

US Patent Granted for Batu Biologics Cancer Immunotherapeutic Product ImmXcyteTM

Apr 17, 2015

Emotional Brain Obtains Patent Extension for its Female Sexual Dysfunction Medication

Apr 16, 2015

Medac Pharma, Inc. Announces Settlement Of Patent Infringement Lawsuits

Apr 7, 2015

MicroBiome Therapeutics Reports Advances In Three Microbiome Modulator Programs As It Launches Series B Financing

Mar 31, 2015

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Crohn's Disease

Feb 9, 2015

MicroBiome Therapeutics Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity

Feb 5, 2015

Neuronascent Announces Expanded Patent Coverage in US and Russia for Its Alzheimer's Disease and Down Syndrome Therapeutics

Jan 14, 2015

3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb targeting VEGFR2 and Tie-2 with PharmAbcine

Jan 5, 2015

Alzheon Announces Patent Allowance in Europe for ALZ-801 in Development for Alzheimer’s Disease

Dec 1, 2014

European Patent Office Grants Broad RNAa Patent from Corey Estate Exclusively Licensed by MiNA Therapeutics

Nov 18, 2014

Aphios Granted United States Patent for Nanotechnology Co-Encapsulation of Combination Drugs and Drug Products

Nov 18, 2014

3SBio Signs Exclusive Patent License Agreement for Tanibirumab, an Anti-VEGFR2/KDR mAb with PharmAbcine

Nov 6, 2014

ViaCyte Receives U.S. Patent Claiming Alternative Methods to Manufacture Pancreatic Progenitor Cells In Vitro

Aug 11, 2014

EnGeneIC Receives Patent from the USPTO for EDV™ Nanocell Technology

Jun 17, 2014

ArmaGen Receives Notice of Allowance for U.S. Patent Covering Novel Investigational Therapy for Hunter Syndrome

May 29, 2014

ViaCyte and Asterias Biotherapeutics Settle Patent Dispute

May 23, 2014

Batu Biologics Files Patent Covering its Proprietary Cancer Vaccine Targeting the Tumor Endothelium: Vallovax

May 15, 2014

Alzheon Announces Notice of Allowance for U.S. Patent for its Lead Drug Candidate ALZ-801 in Clinical Development for Alzheimer’s Disease

May 9, 2014

Batu Biologics Files Patent Covering New Use of Approved Drug for Decreasing Cancer Immunotherapy Toxicity

Apr 1, 2014

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

Apr 1, 2014

Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval

Mar 25, 2014

AvidBiotics Granted U.S. Patent for Novel Immunotherapeutic Platform

Mar 19, 2014

AvidBiotics Granted U.S. Patent for Bactericidal Proteins that Selectively Kill C. Difficile

Mar 11, 2014

Medac Pharma, Inc. Announces the Issuance of U.S. Patent for Treating Autoimmune Diseases with Concentrated Methotrexate Solutions of More Than 30 mg/ml

Feb 14, 2014

Acacia Subsidiary Enters into Patent License Agreement with Braeburn Systems LLC

Feb 3, 2014

Curemark Receives Worldwide Patent Coverage For Enzyme Delivery System

Jan 29, 2014

Neuronascent, Inc. Announces Issuance of US Patent Covering Second-Generation Neurorestorative Therapeutic Candidate

Jan 27, 2014

Medac Pharma, Inc. Secures FDA Acceptance of a New Drug Application (NDA) for Methotrexate-Containing Autopen

Jan 22, 2014

Qu Biologics Granted Broad Australian Patent for Targeted Treatment of Multiple Cancers

Jan 8, 2014

Veloxis Pharmaceuticals Receives Notice of Allowance from U.S. Patent Office for Diurnal-Independent Administration of Envarsus

Jan 8, 2014

Aphios Granted United States Patent for Pretreating Cellulosic Biomass to Manufacture Biofuels and Biochemicals

Dec 6, 2013

Qu Biologics Granted Broad European Patent for Targeted Treatment of Multiple Cancers

Dec 2, 2013

Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT

Nov 6, 2013

Court Upholds $115 Million Judgment in Patent Case Filed by Syntrix Biosystems against Illumina, Inc.

Nov 4, 2013

Aphios Granted United States Patent for Oral Delivery of Cannabinoids Such as Δ9-THC in Nanoparticles

Oct 9, 2013

Kymab Defends Patent Action in UK

Sep 4, 2013

ARMAGEN Expands Patent Portfolio With Issuance Of Two Additional U.S. Patents

Aug 9, 2013

Curemark Awarded New Patent For Treatment Of Drug And Alcohol Addiction

Jul 31, 2013

Factor Bioscience Granted First U.S. Patent for RNA-Based Reprogramming Technology

Jun 25, 2013

Neuronascent, Inc. Announces Issuance of Canadian Patent Covering Its Lead Alzheimer's Disease Candidate

Jun 20, 2013

Syntrix Biosystems Wins Final Judgment of $115 Million in Patent Case against Illumina, Inc.

Jun 5, 2013

Precision BioSciences Files Patent Infringement Lawsuit against Lonza Related to GS XceedTM Gene Expression System

Jun 4, 2013

OxThera Strengthens Patent Portfolio for Orphan Disease - Primary Hyperoxaluria

May 6, 2013

Precision BioSciences Wins Patent Infringement Lawsuit against Cellectis

Mar 4, 2013

Aphios Granted United States Patent for Zindol

Feb 19, 2013

Precision BioSciences Awarded Patent for Genetically Modifying Cells by the United States Patent Office

Feb 4, 2013

KAHR Medical Granted U.S. Patent Approval for One of its Lead Products in Development, KAHR-101

Dec 19, 2012

CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding

Nov 27, 2012

Curemark Announces New Patent Covering Treatment Of Drug And Alcohol Addiction

Nov 6, 2012

Precision BioSciences Files Patent Infringement Lawsuit Against Cellectis Related to Gene Editing Technology

Oct 29, 2012

Precision BioSciences Announces Allowance of Eleventh U.S. Patent Application Related to Genome Editing Nucleases

Sep 19, 2012

Clarus Therapeutics Strengthens Patent Estate with Issuance of a U.S. Patent Directed to Formulations and Method of Use of Clarus' Oral Testosterone Product

Jul 25, 2012

Discgenics Receives "Notice of Issuance" on its First U.S. Patent Application

May 23, 2012

MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent

Feb 6, 2012

Precision BioSciences Announces Allowances in Fifth and Sixth U.S. Patent Applications Related to Engineered Meganucleases

Jan 30, 2012

Precision BioSciences Announces Allowance of Third U.S. Patent Related to Engineered Meganucleases

Jan 25, 2012

Precision BioSciences Announces Allowance of Second U.S. Patent for Engineered Meganucleases

Jan 23, 2012

Precision BioSciences Announces that the US Patent Office Rejects All Claims to Cellectis Patent

Nov 22, 2011

BioFactura Awarded US Patent for its StableFastTM Biomanufacturing Platform

Oct 6, 2011

Precision BioSciences Sues Cellectis for Patent Infringement

Sep 27, 2011

Precision BioSciences Awarded Broad Meganuclease Patent by the USPTO

Sep 8, 2011

Curemark Issued Patent for the Diagnosis of Parkinson's Disease

Jul 11, 2011

EffRx Announces Issuance of US Patent Providing Further Protection to EX101, Effervescent Alendronate Weekly Dosing Form

Jun 16, 2011

Tioga Pharmaceuticals Issued Key U.S. Patent for the Use of Asimadoline to Treat D-IBS

May 11, 2011

U.S. Patent Office Grants Dyax Corp.’s Request for an Interference with U.S. Patent No. 7,700,302 Issued to Adimab

Mar 7, 2011

Symphogen Receives US Patent on Lead Cancer Compound Sym004

Jan 5, 2011

Gliknik Announces Completion of Equity Financing

Sep 8, 2010

Nautilus Neurosciences and APR Applied Pharma Research s.a. Announce Extension of Patent Protection for CAMBIA™ (Diclofenac Potassium for Oral Solution) Through 2026

Jun 17, 2010

Precision BioSciences Announces that the US Patent Office Action Issues Second Actions Rejecting All Claims Asserted by Cellectis in Litigation

May 27, 2010

Numerate’s Ranking Technology for Pharmaceutical R&D Gains U.S. Patent

May 27, 2010

Numerate’s Ranking Technology for Pharmaceutical RandD Gains U.S. Patent

Feb 16, 2010

CalciMedica Announces Issuance of US Patent No. 7,645,588, a Composition Patent Involving STIM1, a Key Component of the CRAC Channel

Nov 19, 2009

Precision BioSciences Announces that Cellectis Loses Patent Protection for Single-Chain Meganucleases in Europe

May 7, 2007

Symphogen Granted European Patent Covering Use of Polyclonal Antibodies for Allergy Indications